We are live on ! Find out more
ASTH icon

Astrana Health

162 hedge funds and large institutions have $642M invested in Astrana Health in 2025 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 54 increasing their positions, 54 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,335% more call options, than puts

Call options by funds: $12.9M | Put options by funds: $898K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 54

0.65% less ownership

Funds ownership: 46.59%45.94% (-0.65%)

9% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 35

4% less funds holding

Funds holding: 168162 (-6)

21% less capital invested

Capital invested by funds: $813M → $642M (-$171M)

Holders
162
Holders Change
-6
Holders Change %
-3.57%
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
32
Increased
54
Reduced
54
Closed
35
Calls
$12.9M
Puts
$898K
Net Calls
+$12M
Net Calls Change
+$14.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$3.33M +$350K +12,437 +10%
Axa
27
Axa
France
$3.15M +$3.57M +126,614 New
HSA
28
Hussman Strategic Advisors
Maryland
$3.13M +$1.18M +42,000 +50%
Millennium Management
29
Millennium Management
New York
$3.12M +$3.53M +125,349 New
Legal & General Group
30
Legal & General Group
United Kingdom
$2.91M -$134K -4,751 -4%
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$2.9M +$48.3K +1,714 +1%
Renaissance Technologies
32
Renaissance Technologies
New York
$2.38M -$2.62M -93,100 -49%
Squarepoint
33
Squarepoint
New York
$2.38M +$2.22M +78,951 +475%
UBS Group
34
UBS Group
Switzerland
$2.31M +$1.66K +59 +0.1%
JP Morgan Chase
35
JP Morgan Chase
New York
$2.29M +$620K +22,030 +31%
N
36
Nuveen
North Carolina
$2.2M -$571K -20,266 -19%
Jane Street
37
Jane Street
New York
$2.19M +$1.42M +50,258 +133%
Bank of America
38
Bank of America
North Carolina
$2.15M -$394K -13,986 -14%
WP
39
Westmount Partners
California
$2.14M -$53.2K -1,890 -2%
Swiss National Bank
40
Swiss National Bank
Switzerland
$2.14M -$36.6K -1,300 -1%
Barclays
41
Barclays
United Kingdom
$2.03M +$669K +23,767 +41%
FMI
42
F/M Investments
District of Columbia
$1.82M +$2.87K +102 +0.1%
Balyasny Asset Management
43
Balyasny Asset Management
Illinois
$1.82M +$114K +4,051 +6%
Prudential Financial
44
Prudential Financial
New Jersey
$1.72M +$65.9K +2,340 +6%
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$1.61M +$1.02M +36,378 +128%
IIM
46
INTECH Investment Management
Florida
$1.52M +$468K +16,635 +37%
Citigroup
47
Citigroup
New York
$1.41M -$209K -7,426 -12%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$1.36M -$44.5K -1,581 -3%
AllianceBernstein
49
AllianceBernstein
Tennessee
$1.26M
New York State Teachers Retirement System (NYSTRS)
50
New York State Teachers Retirement System (NYSTRS)
New York
$1.08M +$2.82K +100 +0.2%

ASTH Hedge Fund Activity: Q2 2025 in Review

162 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q2 2025, worth a combined $642M — down 21% from $813M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of ASTH and 32 opened new positions — a net loss of 3 holders — while 54 trimmed existing stakes and 54 added.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $5.13M. The largest seller was Fidelity Investments, cutting an estimated $9.57M.

  • 162 institutional investors held Astrana Health (ASTH) as of Q2 2025, down from 168 in Q1 2025.
  • Funds reported $642M of Astrana Health stock for Q2 2025, down 21% quarter-over-quarter.
  • 32 funds opened new Astrana Health positions in Q2 2025 and 35 closed out, a net change of -3 holders.
  • The largest Astrana Health buyer in Q2 2025 was Jacobs Levy Equity Management, an estimated $5.13M added.
  • The largest Astrana Health seller in Q2 2025 was Fidelity Investments, an estimated $9.57M sold.

Based on aggregated 13F filings for Q2 2025.